Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial cell surface binding proteins (IEC-SBPs) represent a heterogeneous group of proteins located on the apical membrane of enterocytes that facilitate the interaction between the host and the luminal environment. This category includes various molecular entities such as receptors (e.g., Guanylate cyclase-C), transporters (e.g., PEPT1, SGLT1), and enzymes (e.g., Aminopeptidase N), which are vital for nutrient absorption, fluid homeostasis, and immune surveillance (Abreu, 2010; Waldman & Camilleri, 2018). These proteins also serve as critical attachment sites for enteric pathogens, including bacteria like Escherichia coli and various viruses, which exploit them to initiate infection (Ribet & Cossart, 2015). In the pharmaceutical industry, these proteins are targeted by drugs such as linaclotide to treat gastrointestinal motility disorders or are utilized in the design of oral vaccines and targeted drug delivery systems to enhance mucosal immunity and drug bioavailability (Maeda et al., 2013). Because the term describes a functional class rather than a specific molecular target, it is considered a broad category in pharmacological research. The expression and function of these proteins are often modulated by the gut microbiota and inflammatory states, influencing both health and disease.
Agonism of surface receptors to modulate fluid secretion, inhibition of transporters to manage electrolyte balance, or blocking of adhesion sites to prevent infection.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell surface binding proteins.